Company: ALCE
Filing Date: 2025-01-27
Form Type: S-1
Source: 0001213900-25-007054
Chunk: 3

Company: Alternus Clean Energy, Inc.
Filing Date: 2025-01-27
Form: S-1
Chunk 3
---
ARED EFFECTIVE. THIS PRELIMINARY PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND WE ARE NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE OR OTHER JURISDICTION WHERE THE OFFER OR SALE IS NOT PERMITTED.

ALTERNUS CLEAN ENERGY, INC. Up to [●] Units, with each Unit consisting of: One Share of Common Stock One Series A Warrant to Purchase One Share of Common Stock One Series B Warrant to Purchase One Share of Common Stock Up to [●] Pre-Funded Units, with each Pre-Funded Unit consisting of: One Pre-Funded Warrant to Purchase One Share of Common Stock One Series A Warrant to Purchase One Share of Common Stock One Series B Warrant to Purchase one Share of Common Stock Up to [●] Shares of Common Stock Underlying the Pre-Funded Warrants Up to Shares of Common Stock Underlying the Series A Warrants Up to Shares of Common Stock Underlying the Series B Warrants Alternus Clean Energy, Inc. (the “ Company,” “ Alternus,” the “ registrant,” “ we,” “ our” or “ us”) is offering up to [●] units (the “ Common Units”), each Common Unit consisting of: (i) one share of common stock $0.0001 par value per share (the “ common stock”); and (ii) one Series A Warrant to purchase one share of common stock (the “ Series A Warrants”); and (iii) one Series B Warrant to purchase one share of common stock (the “ Series B Warrants),” together with the Series A Warrants, the “ Warrants”). Each Series A Warrant is exercisable at an exercise price of $[●] per share (150% of the public offering price per Common Unit), subject to certain anti-dilution and share combination event protections, and each Series B Warrant is exercisable at an exercise price of $[●] per share (150% of the public offering price per Common Unit) subject to certain share combination event protections. The Series A Warrants will be exercisable commencing upon our receipt of the Warrant Stockholder Approval (described below) and will expire [●] years after the date of the Warrant Stockholder Approval and the Series B Warrants will be exercisable commencing upon our receipt of the Warrant Stockholder Approval and will expire [●] years from the date of Warrant